Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.02 | $0.03 | $0.02 |
| Q2 2026 | 1 | $0.01 | $0.03 | $0.03 |
| Q3 2026 | 2 | $0.03 | $0.05 | $0.05 |
| Q4 2026 | 1 | $0.06 | $0.06 | $0.06 |
| Q1 2027 | 1 | $0.08 | $0.08 | $0.08 |
| Q2 2027 | 1 | $0.08 | $0.08 | $0.08 |
| Q3 2027 | 1 | $0.09 | $0.10 | $0.10 |
| Q4 2027 | 1 | $0.10 | $0.11 | $0.11 |
| Q1 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 1 | $0.00 | $0.00 | $0.00 |
Biolife Solutions Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.03. The company had revenue of 27.50 M for the quarter and had revenue of 96.21 M for the year. Biolife Solutions Inc has generated $0 earnings per share over the last year ($-0.25 diluted earnings per share) and currently has a price-to-earnings ratio of -97.74. Biolife Solutions Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | $0.01 | $0.02 | 0.01 | $25.66 M | $27.50 M |
| 02/26/2026 | Q4 2025 | -$0.02 | $0.08 | 0.1 | $24.08 M | $18.79 M |
| 11/06/2025 | Q3 2025 | $0.00 | $0.01 | 0.01 | $25.69 M | $28.07 M |
| 08/07/2025 | Q2 2025 | -$0.03 | -$0.33 | -0.3 | $23.71 M | $25.42 M |
| 05/08/2025 | Q1 2025 | -$0.05 | -$0.01 | 0.04 | $22.22 M | $23.94 M |
| 03/03/2025 | Q4 2024 | -$0.06 | $0.27 | 0.33 | $21.67 M | $-3,424,000 |
| 11/12/2024 | Q3 2024 | -$0.08 | -$0.04 | 0.04 | $25.54 M | $30.57 M |
| 08/09/2024 | Q2 2024 | N/A | -$0.45 | N/A | $23.95 M | $19.72 M |
| 05/10/2024 | Q1 2024 | N/A | -$0.22 | N/A | $26.01 M | $18.43 M |
| 02/29/2024 | Q4 2023 | -$0.34 | -$0.30 | 0.04 | N/A | $17.39 M |
| 11/09/2023 | Q3 2023 | -$0.38 | -$0.67 | -0.3 | N/A | $23.57 M |
| 08/09/2023 | Q2 2023 | N/A | -$0.23 | N/A | N/A | $39.51 M |
| 05/11/2023 | Q1 2023 | N/A | -$0.32 | N/A | N/A | $37.70 M |
| 03/31/2023 | Q4 2022 | N/A | -$1.15 | N/A | N/A | $44.26 M |
| 11/09/2022 | Q3 2022 | -$0.17 | -$0.23 | -0.06 | N/A | $40.75 M |
| 08/09/2022 | Q2 2022 | -$0.21 | -$1.72 | -1.51 | N/A | $40.53 M |
| 05/10/2022 | Q1 2022 | N/A | -$0.18 | N/A | N/A | $36.22 M |
| 03/31/2022 | Q4 2021 | N/A | -$0.37 | N/A | N/A | $37.30 M |
| 11/15/2021 | Q3 2021 | N/A | $0.00 | N/A | N/A | $33.80 M |
| 08/16/2021 | Q2 2021 | N/A | $0.20 | N/A | N/A | $31.20 M |
In the previous quarter, Biolife Solutions Inc (:BLFS) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.03.
The conference call for Biolife Solutions Inc's latest earnings report can be listened to online.
The conference call transcript for Biolife Solutions Inc's latest earnings report can be read online.
Biolife Solutions Inc (:BLFS) has a recorded annual revenue of $96.21 M.
Biolife Solutions Inc (:BLFS) has a recorded net income of $-12,130,000.Biolife Solutions Inc has generated $-0.25 earnings per share over the last four quarters.
Biolife Solutions Inc (:BLFS) has a price-to-earnings ratio of -97.74 and price/earnings-to-growth ratio is 0.14.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED